Bristol-Myers Squibb (BMY) Poised for Upside With Registrational Data Ahead [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Bristol-Myers Squibb Company (NYSE:BMY) to $60 from $54 on January 13, maintaining an Outperform rating on the company's shares. The firm cited substantial pipeline flexibility in 2026 as the key justification for the higher target. Pixabay/Public Domain Leerink decreased its fourth-quarter 2025 earnings per share forecast by 29%, from $1.65 to $1.19, citing expected IPR&D expenses of $1,393 million and licensing income of $222 million. Moreover, Bristol-Myers Squibb Company (NYSE:BMY) presented a summary of its portfolio readings at a conference on January 12, noting 12 registrational data readings from eight assets expected this year, with the majority representing significant advancement potential. Leerink believes investors are now greatly discounting most pipeline candidates, suggesting huge upside potential if clinical trial findings are favorable. Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company focused on discovering, developing, and delive
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol Myers Squibb (NYSE:BMY) had its price target raised by analysts at Citigroup Inc. from $60.00 to $64.00. They now have a "neutral" rating on the stock.MarketBeat
- Bristol Myers Squibb (NYSE:BMY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- What Catalysts Are Rewriting The Story For Bristol Myers Squibb (BMY)? [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (NYSE:BMY) had its "buy" rating reaffirmed by analysts at Guggenheim.MarketBeat
- Bristol Myers Squibb (NYSE:BMY) had its "outperform" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 2/5/26 - Form 8-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- BMY's page on the SEC website